News
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
1don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.
The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday. The move ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
7don MSN
Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday. The updated shot targets the LP.8.1 variant, ...
Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...
Hosted on MSN2mon
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The primary efficacy was to demonstrate the vaccine efficacy against COVID-19 starting 14 days after mNEXSPIKE compared with Spikevax, Moderna's updated COVID-19 vaccine approved on Sept. 6, 2024.
Moderna announced Wednesday that the first trial volunteers have received boosters of their COVID-19 vaccine, some of them modified to target a variant.
Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...
WASHINGTON — The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results